HELP     Sign In
Search

Relevance to Autism

Two de novo missense variants in the TET2 gene have been identified in ASD probands from the Simons Simplex Collection, with no de novo events in this gene observed in 1,786 unaffected siblings (P=0.02) (Iossifov et al., 2014; Krumm et al., 2015).

Molecular Function

The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. In addition to its role in DNA demethylation, TET2 isalso involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
The contribution of de novo coding mutations to autism spectrum disorder
ASD
Support
Genome-wide characteristics of de novo mutations in autism
ASD
Support
Excess of rare, inherited truncating mutations in autism.
ASD
Support
ASD
Support
Integrating de novo and inherited variants in 42
ASD
Support
2022
TS
Support
Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder.
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN728R001 
 missense_variant 
 c.5008C>T 
 p.Leu1670Phe 
 De novo 
  
 Simplex 
 GEN728R002 
 missense_variant 
 c.789G>T 
 p.Glu263Asp 
 De novo 
  
 Simplex 
 GEN728R003 
 missense_variant 
 c.2392G>A 
 p.Glu798Lys 
 De novo 
  
 Simplex 
 GEN728R004 
 missense_variant 
 c.3847G>T 
 p.Ala1283Ser 
 Familial 
  
 Simplex 
 GEN728R005a 
 stop_gained 
 c.1648C>T 
 p.Arg550Ter 
 De novo 
  
  
 GEN728R005b 
 stop_gained 
 c.5725G>T 
 p.Glu1909Ter 
 De novo 
  
  
 GEN728R006 
 missense_variant 
 c.3785G>C 
 p.Arg1262Pro 
 De novo 
  
 Simplex 
 GEN728R007 
 stop_gained 
 c.2861G>A 
 p.Trp954Ter 
 De novo 
  
  
 GEN728R008 
 synonymous_variant 
 c.1422G>A 
 p.Pro474%3D 
 De novo 
  
 Simplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
4
Duplication
 1
 
4
Duplication
 1
 
4
Deletion-Duplication
 12
 

Model Summary

Variation in DHX genes, including DHX9, has been linked to neurodevelopmental disorders including autism spectrum disorder (ASD). The homozygous knockout model shows no change in viability but exhibits decreased body weight compared to sex-matched wildtypes. The model also shows altered behavioral and neurological function. Male and female model mice show decreased locomotion, with a decrease in distance traveled in the periphery of the open field and a decrease in locomotor speed. Additionally, model male and female mice demonstrate decreased grip strength, increased tremor, and decreased auditory functioning, as measured by the auditory brainstem response test. Furthermore, the model shows altered metabolic function, with possible altered renal function, decreased glucose clearance, and decreased cholesterol levels.

References

Type
Title
Author, Year

M_TET2_1_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: A targeting vector was designed to place an FRT- and loxP-flanked neomycin resistance cassette upstream of exon 3 and a loxP site downstream of exon 3. The construct was electroporated into BAC-BA1(129S/SvEV x C57BL/6)-derived embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts. Strong chimeras were identified and crossed to C57BL/6 females to verify germline transmission. The F1 generation was PCR screened and crossed to 129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J (JR#003946) to remove the FRT neo cassette.
Allele Type: Conditional knockout
Strain of Origin: (C57BL/6 x 129S/SvEv)F1
Genetic Background: C57BL/6N
ES Cell Line:
Mutant ES Cell Line:
Model Source: Jackson Laboratory

M_TET2_2_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: A transgenic construct containing a human growth hormone polyadenylation signal and a Cre recombinase gene under the control of the promoter and the nervous system-specific enhancer present in the second intron of the rat nestin gene, was injected into B6SJLF2 oocytes. Founder animals were bred to wildtype C57BL/6J mice. The mice were then backcrossed to C57BL/6J for at least six generations. After its arrival at The Jackson Laboratory, it was crossed to C57BL/6J (Stock No. 000664) for another four generations.
Allele Type: Conditional knockout
Strain of Origin: (C57BL/6 x SJL)F2
Genetic Background:
ES Cell Line:
Mutant ES Cell Line:
Model Source: Jackson Laboratory

M_TET2_3_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: CaMKII-alpha-Cre viruses targeting glutamatergic neurons were bilateraly injected into the LHb of Tet2 loxP/loxP mice at 8 weeks, resulting in Tet2 deficiency in glutamatergic neurons.
Allele Type: Conditional knockout
Strain of Origin:
Genetic Background:
ES Cell Line:
Mutant ES Cell Line:
Model Source: Jackson Laboratory

M_TET2_1_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal activation: locomotion1
Increased
Description: Tet2 mutant mice exhibited increased activity in lateral habenula neurons compared to wildtype controls, as indicated by the relative fluorescence intensity change.
Exp Paradigm: lateral habenula neurons
 Fiber photometry
 not specified
Neuronal activation: non-familiar social interaction1
Decreased
Description: Tet2 mutant mice exhibited no change in activity in lateral habenula neurons during the interaction with a stranger mouse compared to an object, while wildtype controls exhibited an increase in activity during the interaction with the stranger mouse compared to the object. Additionally, Tet2 mutant mice exhibited no change in the percentage of ON neurons during social interaction, object sniffing, or self-directed activity, while wildtype mice exhibited a significant increase in the percentage of ON neurons during social interaction compared to the other two behaviors.
Exp Paradigm: lateral habenula neurons
 Fiber photometry
 not specified
Social memory1
Decreased
Description: Tet2 male mutant mice exhibited a significant decrease in the time spent exploring a novel mouse (s2) as opposed to a familiar mouse (s1) compared to wildtype controls, suggesting a deficit in social memory.
Exp Paradigm: familiar mouse in chamber 1 (s1), stranger mouse (s2) in chamber 2
 Three-chamber social approach test
 8-16 weeks
Social approach1
Decreased
Description: Tet2 male mutant mice exhibited a significant decrease in time spent sniffing a stranger mouse (as opposed to an empty cage) compared to wildtype controls, as further exhibited by a significant decrease in social preference index.
Exp Paradigm: stranger mouse (s1) in chamber 1, empty cage (object) in chamber 2
 Three-chamber social approach test
 8-16 weeks
Targeted expression1
Decreased
Description: Tet2 mutant mice exhibited a significant decrease in Tet2 protein levels in the lateral habenula compared to wildtype controls.
Exp Paradigm: lateral habenula
 Western blot
 not specified
Anxiety1
 No change
 Open field test
 8-16 weeks
Protein expression level evidence1
 No change
 Western blot
 not specified
General locomotor activity1
 No change
 Open field test
 8-16 weeks
Repetitive digging1
 No change
 Marble-burying test
 8-16 weeks
Self grooming1
 No change
 General observations
 8-16 weeks
 Not Reported:

M_TET2_2_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Social approach1
Decreased
Description: Tet2 male mutant mice exhibited a significant decrease in time spent sniffing a stranger mouse (as opposed to an empty cage) compared to wildtype controls, as further exhibited by a significant decrease in social preference index.
Exp Paradigm: stranger mouse (s1) in chamber 1, empty cage (object) in chamber 2
 Three-chamber social approach test
 8-16 weeks
Depression1
Increased
Description: Tet2 male mutant mice exhibited a significant increase in immobility time compared to control mice.
 Tail suspension test
 8-16 weeks
Targeted expression1
Decreased
Description: Tet2 mutant mice exhibited significantly decreased Tet2 protein levels in the lateral habenula.
Exp Paradigm: lateral habenula
 Western blot
 not specified
Anxiety1
 No change
 Open field test
 8-16 weeks
General locomotor activity1
 No change
 Open field test
 8-16 weeks
Social memory1
 No change
 Three-chamber social approach test
 8-16 weeks
 Not Reported:

M_TET2_3_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Social memory1
Decreased
Description: Tet2 male mutant mice exhibited a significant decrease in the time spent exploring a novel mouse (s2) as opposed to a familiar mouse (s1) compared to wildtype controls, suggesting a deficit in social memory.
Exp Paradigm: familiar mouse in chamber 1 (s1), stranger mouse (s2) in chamber 2
 Three-chamber social approach test
 8-16 weeks
Social approach1
Decreased
Description: Tet2 mutant mice exhibited a significant decrease in time spent sniffing a stranger mouse (as opposed to an empty cage) compared to control mice, as further exhibited by a significant decrease in social preference index.
Exp Paradigm: stranger mouse (s1) in chamber 1, empty cage (object) in chamber 2
 Three-chamber social approach test
 8-16 weeks
Differential gene expression1
Decreased
Description: Tet2 mutant mice exhibited significantly decreased Sh3rf2 gene expression compared to wildtype control mice.
 Quantitative PCR (qRT-PCR)
 not specified
Differential gene expression1
Abnormal
Description: Tet2 mutant mice displayed 382 differentially expressed genes, including 161 genes that were up-regulated and 221 genes that were down- regulated.
 RNA sequencing
 not specified
Targeted expression1
Decreased
Description: Tet2 mutant mice exhibited significantly decreased Tet2 protein levels in the habenula compared to control mice.
Exp Paradigm: habenula
 Western blot
 not specified
Anxiety1
 No change
 Open field test
 8-16 weeks
General locomotor activity1
 No change
 Open field test
 8-16 weeks
 Not Reported:

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.